What drug will return a patient with tachycardia to sinus rhythm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Tachycardia with HR 180 bpm

Adenosine is the drug of choice to rapidly convert a patient with a heart rate of 180 bpm to sinus rhythm. 1

Mechanism of Action and Efficacy

Adenosine works by temporarily blocking the AV node, interrupting the reentrant circuit that maintains many forms of supraventricular tachycardia (SVT). It has a rapid onset of action (within seconds) and an extremely short half-life (less than 10 seconds), making it ideal for acute conversion of SVT to sinus rhythm.

Decision Algorithm for Tachycardia Management

  1. Initial Assessment:

    • For hemodynamically unstable patients: Immediate synchronized cardioversion 1
    • For hemodynamically stable patients with regular tachycardia: Proceed with pharmacologic management
  2. First-line Therapy:

    • Vagal maneuvers (Valsalva, carotid sinus massage) 1
    • If unsuccessful, proceed to adenosine
  3. Adenosine Administration:

    • Initial dose: 6 mg rapid IV push followed by saline flush
    • If ineffective, give 12 mg IV push (can repeat once if needed)
    • Adenosine is particularly effective for:
      • AV nodal reentrant tachycardia (AVNRT)
      • AV reentrant tachycardia (AVRT)
      • Sinus node reentry tachycardia 1

Why Not Flecainide or Digoxin?

  • Flecainide (Option B):

    • Less effective for acute conversion of SVT 1
    • Studies show poor efficacy for acute conversion compared to other options 1
    • Has significant risks in patients with structural heart disease
    • Requires more time to take effect compared to adenosine
  • Digoxin (Option C):

    • Ineffective for acute conversion to sinus rhythm 1
    • Only slows ventricular rate without converting to sinus rhythm in most cases
    • Guidelines specifically state: "In patients with AF following cardiac surgery, we cannot at this time recommend using flecainide, digoxin, or calcium channel blockers for the purpose of conversion to sinus rhythm" 1
    • Conversion rates with digoxin are similar to placebo, consistent with the self-limited natural history of some arrhythmias rather than drug efficacy 1

Special Considerations

  1. Caution with adenosine:

    • Brief side effects may include flushing, chest discomfort, and transient asystole
    • Contraindicated in patients with severe asthma or advanced AV block
    • Should be used with caution in patients with severe coronary artery disease 1
  2. Alternative options if adenosine fails or is contraindicated:

    • IV beta-blockers (e.g., metoprolol)
    • IV calcium channel blockers (e.g., verapamil, diltiazem)
    • IV amiodarone (particularly in patients with heart failure) 1
  3. Monitoring during administration:

    • Continuous ECG monitoring is essential
    • Have resuscitation equipment immediately available
    • Be prepared for potential transient asystole

In conclusion, adenosine is the most appropriate choice for rapidly converting a patient with a heart rate of 180 bpm to sinus rhythm due to its rapid onset, high efficacy in SVT, and excellent safety profile when used appropriately.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.